医院运营管理
Search documents
滨医附院成功举办全国医院运营管理与4D识人专题培训班
Sou Hu Cai Jing· 2025-12-23 14:18
Liness Quante . 20 全国巡讲第166期《运营管理 2025年12月18- Description in Court 国法:40 . UN e - Box 54 Home Boo 6535 2017 EWIE p 17 10 400 会议现场 为深入贯彻落实健康中国战略,助力医疗机构提升运营管理与内涵建设,12月18日至21日,滨州医学院附属医院联合山东省医院协会医务管理专业委员会、 成功使者集团共同主办全国医院运营管理与4D识人专题培训班,来自全国各级医疗卫生机构的百余位管理精英齐聚一堂,共商管理创新之道,共谋医院发 展新篇。 部分别住宅1901 澳洲星期前时候运输 滨医附院党委书记王东致辞 滨医附院党委书记、山东省医院协会医务管理专业委员会主任委员王东出席开幕式并致辞。他在致辞中指出,当前医院管理正从"经验驱动"转向"科学赋 能",提升运营管理素养、掌握科学识人方法,既是新时代医院管理者的"必修课",也是推动医院高质量发展的"关键招"。他希望通过此次培训搭建一个学 思践悟、互学互鉴的优质平台,以创新理念破解发展难题,以务实举措应对行业变革,共同推动医疗卫生事业高质量发展。 刘邦的识人用人智 ...
明基医院(02581.HK) 12月12日—12月17日招股
Zheng Quan Shi Bao Wang· 2025-12-12 02:19
Core Viewpoint - BenQ Hospital (02581.HK) plans to globally offer 67 million shares, with a maximum offer price of HKD 11.68 per share, aiming to raise approximately HKD 704 million for various expansion and operational purposes [1] Group 1: Share Offering Details - The global offering consists of 6.7 million shares for Hong Kong and 60.3 million shares for international investors [1] - The subscription period is set from December 12 to December 17, with an entry fee of approximately HKD 5,898.90 for a board lot of 500 shares [1] - The expected net proceeds from the offering are HKD 626 million, which will be used for hospital expansion, potential investments and acquisitions, upgrading to a "smart hospital," and general working capital [1] Group 2: Financial Performance - The company's net profit for the fiscal years ending June 30, 2023, 2024, and the first half of 2025 is projected to be CNY 167 million, CNY 109 million, and CNY 48.704 million, reflecting year-on-year changes of 86.99%, -34.95%, and -23.18% respectively [2] Group 3: Strategic Partnerships and Market Position - The company has secured cornerstone investors including He Rong Technology Co., Ltd., He Fu (China) Medical Technology Co., Ltd., and Suzhou Zhanxing Investment Fund Partnership [1] - BenQ Hospital draws on advanced hospital management practices from Taiwan and operates as a private for-profit general hospital group in mainland China [1] Group 4: Listing Information - The company is expected to be listed on the main board by December 22, 2025, with China International Capital Corporation Hong Kong Securities Limited and Citigroup Global Markets Asia Limited acting as joint sponsors [1]
明基医院 12月12日—12月17日招股
Zheng Quan Shi Bao Wang· 2025-12-12 01:58
Group 1 - The company, BenQ Hospital, plans to globally offer 67 million shares, with 6.7 million shares available in Hong Kong and 60.3 million shares for international sale [1] - The subscription period is set from December 12 to December 17, with a maximum offer price of HKD 11.68 per share and an entry fee of approximately HKD 5,898.90 for a trading unit of 500 shares [1] - The total expected fundraising amount is HKD 704 million, with a net amount of HKD 626 million, which will be used for hospital expansion and upgrades, potential investments and acquisitions, smart hospital upgrades, and general working capital [1] Group 2 - The company has introduced cornerstone investors including He Rong Technology Co., Ltd., He Fu (China) Medical Technology Co., Ltd., and Suzhou Zhanxing Investment Fund Partnership [1] - BenQ Hospital is expected to be listed on the main board by December 22, 2025, with China International Capital Corporation Hong Kong Securities Limited and Citigroup Global Markets Asia Limited acting as joint sponsors [1] - The company draws on advanced hospital management experience from Taiwan and operates as a private for-profit general hospital group in mainland China [1] Group 3 - For the fiscal years 2023, 2024, and the first half of 2025 ending June 30, the company's net profits are projected to be CNY 167 million, CNY 109 million, and CNY 48.704 million, reflecting year-on-year changes of 86.99%, -34.95%, and -23.18% respectively [2]
明基医院12月12日至12月17日招股 拟全球发售6700万股 引入禾荣科技等基石投资者
Zhi Tong Cai Jing· 2025-12-12 00:14
Core Viewpoint - BenQ Hospital (02581) plans to conduct a global offering of 67 million shares from December 12 to December 17, 2025, with a share price range of HKD 9.34 to HKD 11.68, aiming to list on the Hong Kong Stock Exchange on December 22, 2025 [1] Group 1: Company Overview - The company is a private for-profit general hospital group in mainland China, leveraging advanced hospital management experience from Taiwan [1] - It currently operates two general hospitals and is the largest private for-profit general hospital group in East China, holding a market share of 1.0% in the region [1] - Nationally, it ranks seventh among private for-profit general hospital groups in China, with a market share of 0.4% [1] - The company ranks first in bed revenue among all private for-profit general hospital groups in mainland China for 2024 [1] Group 2: Investment Agreements - The company has entered into cornerstone investment agreements with He Rong Technology, He Fu (China), and Suzhou Zhanxing, totaling USD 39.9 million for share subscriptions [2] - Assuming a share price of HKD 10.51, cornerstone investors will subscribe to approximately 29.55 million shares [2] Group 3: Financial Performance - Revenue increased from RMB 2.336 billion in 2022 to RMB 2.688 billion in 2023, with a slight decrease to RMB 2.659 billion in 2024 [3] - Revenue for the six months ending June 30, 2024, was RMB 1.33 billion, slightly decreasing to RMB 1.313 billion in the corresponding period of 2025 [3] - Gross margin improved from 16.4% in 2022 to 18.9% in 2023, then decreased to 18.1% in 2024 [3] - Net profit for 2022, 2023, and 2024 was RMB 89.6 million, RMB 168 million, and RMB 109 million, respectively, with net profit margins of 3.8%, 6.2%, and 4.1% [3] Group 4: Use of Proceeds - The estimated net proceeds from the global offering, assuming a share price of HKD 10.51, will be approximately HKD 626 million [2] - The intended use of proceeds includes 74.3% for expanding and upgrading existing hospitals, 16.0% for potential investments and acquisitions, 8.0% for upgrading the "Smart Hospital" initiative, and 1.8% for working capital and general corporate purposes [2]
《医院运营管理:方法、实践、案例》,教你轻松“拿捏”运营管理
Sou Hu Cai Jing· 2025-12-08 06:46
《医院运营管理:方法、实践、案例》 (4)医院运营部就是一个财务部的分支,统计上报经济经营数据而已,对医疗服务的改善的实质功效微乎其微; 问题来了:医院有没有必要设置运营部,为什么? 其实当今,在病患对医疗服务的期望越来越高、医疗技术飞速发展、信息网络横行的时代,我觉得一个医院成立一个运营部十分的必要。因此我们首先需 要清楚的认识到以下基本的几点,才能最终建设好运营部。这些很重要,是理念的问题。 在新医改大背景下,向内:随着DRG/DIP对医院"控费"要求提升,医院内部控制压力陡增。由外:随着国家对公立医院高质量发展相关政策意见的出台, 要求医院精细化管理水平逐步提高。 如何推动公立医院核心业务与运营管理工作深度融合,将运营管理转化为价值创造,向精细化管理要效益,实现医疗服务能力与质量双提升,已然成为医 院管理者关注的焦点和亟须应对的挑战。从医院管理的角度来看,公立医院确实非常需要设立医院运营管理部。 很多院长和医院管理者有所不解,医院已经有了那么多的管理部门和管理者,为什么还要设立医院运营部呢?医院运营部主要是根据医院的战略管理与目 标管理,针对医院各种医疗资源、医疗流程和医院绩效管理的评价与成本管理的监控 ...
手把手教你写医院运营管理报告!这样写报告,让主任、院长对你刮目相看!附模版分享!
Sou Hu Cai Jing· 2025-05-26 08:07
作为一名运营管理部的成员,还不知道如何搭建报告框架吗?或者对策没方向,数据也不会用?甚至不懂关键指标咋选?这篇某三甲医院运营管理部总结 的医院运营管理分析报告要点,能帮大家解决写报告时的难题。 从人员、资产到收入、成本等全维度分析逻辑,再到DRG、绩效、效率等核心数据解读,同时教你用对比、象限法精准找问题,给出有具体的成本管 控、绩效优化等落地建议,是新手老手都能快速学会写专业又实用的运营分析报告书写指导。 医院运营管理分析报告书写要点总结 一、遵循政策导向,明确报告定位 政策依据:以《关于加强公立医院运营管理的指导意见》为核心,围绕"全面预算、业务流程"双核心,"全成本管理、绩效管理"双工具,实现"运营效 益、投入产出效率"双提升。 报告目标:融合业务与财务、理论与实践,通过数据驱动分析,为医院运营决策提供支撑。 | | 人力资源:数量、结构、 | | 收入:总量、结构 | | --- | --- | --- | --- | | BEFERE | 人才储备 | 运营网站 | | | | | | 科室贡献 | | 情況 | 资产配置:房屋占用 | 指标 | 成本:结构及变化趋势 | | | 设备资产 | | ...